Key result
G-CSF treatment significantly reduced the cardiomyocyte apoptotic index compared to saline (25.12% vs. 34.51%) and downregulated endoplasmic reticulum stress markers in a rat model of diabetic cardiomyopathy.
Why the study?
Although G-CSF was previously shown to reduce cardiomyocyte apoptosis in diabetic cardiomyopathy, the precise mechanisms associated with this process were not fully understood.
Does G-CSF reduce endoplasmic reticulum stress and cardiomyocyte apoptosis in a rat model of diabetic cardiomyopathy?
Does G-CSF reduce endoplasmic reticulum stress and cardiomyocyte apoptosis in a rat model of diabetic cardiomyopathy?
Absolute Event Rate: 25.12% vs 34.51%
p-value: p=<0.05
In a rat model of diabetic cardiomyopathy, G-CSF improved cardiac diastolic dysfunction and reduced cardiomyocyte apoptosis, likely by downregulating endoplasmic reticulum stress.
No takes yet. Share an insight, caveat, or question.
Preclinical rat data support G-CSF investigation in diabetic cardiomyopathy; leaves open clinical translation.
A 2021 study studied Diabetic cardiomyopathy (n=22). Granulocyte colony-stimulating factor (G-CSF) vs. Saline was evaluated on Cardiomyocyte apoptotic index (p=<0.05). G-CSF treatment significantly reduced the cardiomyocyte apoptotic index compared to saline (25.12% vs. 34.51%) and downregulated endoplasmic reticulum stress markers in a rat model of diabetic cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: